Olaplex Securities Settlement
This settlement is closed to new claims — the deadline was November 24, 2025. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Olaplex is settling a securities class action lawsuit alleging that the company made misrepresentations in its initial public offering documents. The defendant does not admit wrongdoing.
Do you qualify?
Anyone who purchased or otherwise acquired Olaplex Holdings, Inc. publicly traded common stock on or before November 12, 2021, pursuant to the company's initial public offering documents and was allegedly damaged thereby.
How to file
The deadline to submit a claim form was November 24, 2025, and all deadlines have passed. No new claims can be filed.
Common questions
- What is the claim deadline for the Olaplex Securities Settlement?
- This settlement is closed to new claims — the deadline was November 24, 2025. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Is the Olaplex Securities Settlement notice real, or a scam?
- Claims are filed at olaplexsecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Olaplex Securities Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for December 1, 2025; no payments can be issued before a settlement receives final approval.
In the news
Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.